Literature DB >> 15549644

APOE haplotypes influence bone mineral density in Caucasian males but not females.

Ji-Rong Long1, Peng-Yuan Liu, Yong-Jun Liu, Yan Lu, Hui Shen, Lan-Juan Zhao, Dong-Hai Xiong, Hong-Wen Deng.   

Abstract

Low bone mineral density (BMD) is one of the most important risk factors for osteoporosis. Apolipoprotein E (APOE) has been considered as a candidate gene for osteoporosis because of its influence on osteoblast uptake of lipoprotein-borne vitamin K. Using the quantitative transmission disequilibrium test QTDT, we examined linkage and/or association of APOE and BMD at the lumbar spine and the total hip in a sample of 387 Caucasian nuclear families with 715 parents and 953 children. The children were aged 20-50 years and female offspring were premenopausal as well. Four single nucleotide polymorphisms (SNP1-4) in the APOE gene, 4-locus haplotypes and 2-locus haplotypes (epsilon1, epsilon2, epsilon3, epsilon4 isoforms, reconstructed by SNP3 and SNP4) were analyzed. In the whole sample and the female offspring families we found no evidence of linkage or association for either single SNP or haplotype with BMD at the two studied skeletal sites. In the male offspring families, within-family associations were observed at the haplotypes CGTC (P = 0.001), GGTT (P = 0.002), and GATC (P = 0.006) for the lumbar spine BMD, and GATC (P = 0.008) for the total hip BMD. These data suggested that in our studied Caucasian population, APOE may have effects on BMD variation in males but not females. Further studies with a larger sample size are required to confirm such results.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15549644     DOI: 10.1007/s00223-004-0034-z

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  7 in total

Review 1.  Associations of APOE gene polymorphisms with bone mineral density and fracture risk: a meta-analysis.

Authors:  I Peter; M D Crosier; M Yoshida; S L Booth; L A Cupples; B Dawson-Hughes; D Karasik; D P Kiel; J M Ordovas; T A Trikalinos
Journal:  Osteoporos Int       Date:  2010-06-09       Impact factor: 4.507

Review 2.  Molecular genetic studies of gene identification for osteoporosis: a 2004 update.

Authors:  Yong-Jun Liu; Hui Shen; Peng Xiao; Dong-Hai Xiong; Li-Hua Li; Robert R Recker; Hong-Wen Deng
Journal:  J Bone Miner Res       Date:  2006-10       Impact factor: 6.741

Review 3.  Quantitative trait loci, genes, and polymorphisms that regulate bone mineral density in mouse.

Authors:  Qing Xiong; Yan Jiao; Karen A Hasty; S Terry Canale; John M Stuart; Wesley G Beamer; Hong-Wen Deng; David Baylink; Weikuan Gu
Journal:  Genomics       Date:  2009-01-14       Impact factor: 5.736

Review 4.  HDL cholesterol and bone mineral density: is there a genetic link?

Authors:  Cheryl L Ackert-Bicknell
Journal:  Bone       Date:  2012-02       Impact factor: 4.398

5.  Contribution of myostatin gene polymorphisms to normal variation in lean mass, fat mass and peak BMD in Chinese male offspring.

Authors:  Hua Yue; Jin-wei He; Hao Zhang; Chun Wang; Wei-wei Hu; Jie-mei Gu; Yao-hua Ke; Wen-zhen Fu; Yun-qiu Hu; Miao Li; Yu-juan Liu; Song-hua Wu; Zhen-lin Zhang
Journal:  Acta Pharmacol Sin       Date:  2012-03-19       Impact factor: 6.150

6.  Bone mineral density in children and adolescents with neurofibromatosis type 1.

Authors:  David A Stevenson; Laurie J Moyer-Mileur; Mary Murray; Hillarie Slater; Xiaoming Sheng; John C Carey; Bukhosi Dube; David H Viskochil
Journal:  J Pediatr       Date:  2007-01       Impact factor: 4.406

7.  Polymorphisms of genes in the lipid metabolism pathway and risk of biliary tract cancers and stones: a population-based case-control study in Shanghai, China.

Authors:  Gabriella Andreotti; Jinbo Chen; Yu-Tang Gao; Asif Rashid; Bingshu E Chen; Philip Rosenberg; Lori C Sakoda; Jie Deng; Ming-Chang Shen; Bing-Sheng Wang; Tian-Quan Han; Bai-He Zhang; Meredith Yeager; Robert Welch; Stephen Chanock; Joseph F Fraumeni; Ann W Hsing
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-02-22       Impact factor: 4.254

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.